Frontage

Executive Summary

Frontage Laboratories is a global pharmaceutical development organization (PDO) providing integrated laboratory and clinical services to advance drug discovery and development. Founded in 2001 and headquartered in Exton, Pennsylvania, the company offers a comprehensive suite of services spanning drug discovery, preclinical development, bioanalytical testing, CMC, and clinical trial support. With over 500 employees, Frontage serves clients in pharmaceuticals, agrochemicals, and biologics, positioning itself as a strategic partner from early research through clinical phases. Its established track record and broad service portfolio make it a resilient player in the CRO space, though its private status limits visibility into financial performance and near-term catalysts.

Upcoming Catalysts (preview)

• Q1 2027Announcement of a new laboratory facility or capacity expansion70% success
• TBDStrategic partnership with a top-20 pharmaceutical company50% success
• Q4 2026Regulatory accreditation (e.g., CAP/CLIA) for new bioanalytical services80% success